S'abonner

No Observed Difference in Inflammatory and Coagulation Markers Following Diets Rich in n-6 Polyunsaturated Fat vs Monounsaturated Fat in Adults With Untreated Hypercholesterolemia: A Randomized Trial - 18/01/24

Doi : 10.1016/j.jand.2023.08.127 
M. Catherine Prater 1, Alexis R. Scheurell, MS 1, Chad M. Paton, PhD 1, 2, Jamie A. Cooper, PhD 3,
1 Department of Nutritional Sciences, University of Georgia, Athens, Georgia 
2 Department of Food Science and Technology, University of Georgia, Athens, Georgia 
3 Department of Kinesiology, University of Georgia, Athens, Georgia 

Address correspondence to: Jamie A. Cooper, PhD, Department of Kinesiology, University of Georgia, 330 River Rd, Athens, GA 30602.Department of KinesiologyUniversity of Georgia330 River RdAthensGA30602

Abstract

Background

Inflammatory and prothrombotic responses are hallmark to the progression of cardiovascular disease and may be influenced by the type of dietary fat. Cottonseed oil (CSO) is rich in n-6 polyunsaturated fats and improves traditional cardiovascular disease risk factors such as cholesterol profiles. However, some clinicians are still hesitant to promote n-6 polyunsaturated fats consumption despite growing evidence suggesting they may not be independently pro-inflammatory.

Objective

To investigate the inflammatory and coagulation marker responses to an 8-week diet intervention rich in either CSO or olive oil (OO) (OO is rich in monounsaturated fat) in adults with untreated hypercholesterolemia.

Design

This was a secondary analysis of a parallel-arm randomized clinical trial with the main outcome of cholesterol measures.

Participants/setting

Participants included in this analysis were 42 sedentary adults aged 30 to 75 years (62% women) in the Athens, GA, area, between May 2018 and June 2021, with untreated hypercholesterolemia or elevated blood lipids and body mass index >18.5. Hypercholesterolemia was defined as at least two blood lipid levels in a borderline undesirable/at risk range (total cholesterol level ≥180 mg/dL, low-density lipoprotein cholesterol level ≥110 mg/dL, high-density lipoprotein cholesterol level <50 mg/dL, or triglyceride level ≥130 mg/dL), or at least one in an undesirable range (total cholesterol level ≥240 mg/dL, low-density lipoprotein cholesterol level ≥160 mg/dL, high-density lipoprotein cholesterol level <40 mg/dL, or triglyceride level ≥200 mg/dL).

Intervention

Participants were randomly assigned to either the CSO or OO group in a partial outpatient feeding trial. Meals from the study provided approximately 60% of their energy needs with 30% of energy needs from either CSO or OO for 8 weeks. Participants fulfilled their remaining energy needs with meals of their choosing.

Main outcome measures

Fasting plasma concentrations of inflammatory markers, including C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β were measured at baseline and 8 weeks. Markers of coagulation potential, including plasminogen activator inhibitor-1, and tissue factor were measured at the same time points.

Statistical analyses performed

Repeated measures linear mixed models were used with treatment and visit in the model for analyses of all biochemical markers.

Results

There were no significant differences in fasting C-reactive protein (P = 0.70), tumor necrosis factor-α (P = 0.98), interleukin-6 (P = 0.21), interleukin-1β (P = 0.13), plasminogen activator inhibitor-1 (P = 0.29), or tissue factor (P = 0.29) between groups across the intervention.

Conclusions

Inflammation and coagulation marker responses to diets rich in CSO vs OO were not significantly different between groups, and neither group showed changes in these markers in adults with untreated hypercholesterolemia. This provides additional evidence suggesting that dietary n-6 polyunsaturated fats may not promote inflammation compared with monounsaturated fatty acids, even in adults at increased risk for cardiovascular disease.

Le texte complet de cet article est disponible en PDF.

Keywords : C-reactive protein, Tumor necrosis factor-α, Plasminogen activator inhibitor-1, Cottonseed oil, Olive oil


Plan


 Supplementary materials: Figure 4 is available at www.jandonline.org
 STATEMENT OF POTENTIAL CONFLICT OF INTEREST No potential conflict of interest was reported by the authors.
 FUNDING/SUPPORT This study was funded by National Cottonseed Products Association (AWD00009110) and Cotton Incorporated (AWD00012904). This research was also partially supported by the University of Georgia Obesity Initiative. The funders had no role in the design, implementation, analysis and interpretation of the data.
This study was registered at ClinicalTrials.gov, NCT04397055
 AUTHOR CONTRIBUTIONS J. A. Cooper and C. M. Paton conceived the project, provided study oversight, essential reagents and materials. J. A. Cooper, C. M. Paton, and M. C. Prater acquired funding. J. A. Cooper and A. R. Scheurell developed the research methodology. A. R. Scheurell and M. C. Prater conducted the research. M. C. Prater analyzed the data. J. A. Cooper and M. C. Prater wrote the first draft of the manuscript. All authors reviewed and commented on subsequent drafts of the manuscript.


© 2024  Academy of Nutrition and Dietetics. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 124 - N° 2

P. 205 - février 2024 Retour au numéro
Article précédent Article précédent
  • Diet Quality and Body Mass Index Over 20 Years in the Multiethnic Cohort
  • Jenna Tsuzaki, Gertraud Maskarinec, Victoria Mapa, Yurii B. Shvetsov, Song-Yi Park, Kristine R. Monroe, Unhee Lim, Loïc Le Marchand, Carol J. Boushey
| Article suivant Article suivant
  • Increases in New but Not Returning Families to a Midwestern Food Pantry Network During the COVID-19 Pandemic
  • Elizabeth Nix, Nick Dietrich, Jennifer Fralic, Dean Baker

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.